Wada et al. studied and reported that EFNA1 can predict the recurrence risk of patients with radical resection of liver cancer, which may become a prognostic marker [22], and some studies have found that it may be related to the prognosis of cervical cancer [23]. This evidence concerns the gene EFNA1 and liver cancer.